201 related articles for article (PubMed ID: 26671484)
21. Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis.
Daya S; Gunby J; Clark DA
Am J Reprod Immunol; 1998 Feb; 39(2):69-76. PubMed ID: 9506204
[TBL] [Abstract][Full Text] [Related]
22. High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins.
Perricone R; Di Muzio G; Perricone C; Giacomelli R; De Nardo D; Fontana L; De Carolis C
Am J Reprod Immunol; 2006 Mar; 55(3):232-9. PubMed ID: 16451358
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cell activity and cytokine production after in vitro immunoglobulin treatment of lymphocytes derived from pregnant women with or without risk for spontaneous abortion.
Szereday L; Späth P; Szekeres-Bartho J
Am J Reprod Immunol; 1999 Nov; 42(5):282-7. PubMed ID: 10584982
[TBL] [Abstract][Full Text] [Related]
24. Intralipid therapy and adverse reproductive outcome: is there any evidence?
Kumar P; Marron K; Harrity C
Reprod Fertil; 2021 Jul; 2(3):173-186. PubMed ID: 35118388
[TBL] [Abstract][Full Text] [Related]
25. Intralipid as treatment for recurrent unexplained abortion?
Clark DA
Am J Reprod Immunol; 1994 Dec; 32(4):290-3. PubMed ID: 7718096
[TBL] [Abstract][Full Text] [Related]
26. Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational report.
Rogenhofer N; Mahner S; von Hasselbach YL; Thaler CJ
Am J Reprod Immunol; 2022 Feb; 87(2):e13506. PubMed ID: 34935238
[TBL] [Abstract][Full Text] [Related]
27. Duration of intralipid's suppressive effect on NK cell's functional activity.
Roussev RG; Acacio B; Ng SC; Coulam CB
Am J Reprod Immunol; 2008 Sep; 60(3):258-63. PubMed ID: 18782287
[TBL] [Abstract][Full Text] [Related]
28. Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience.
Christiansen OB
Am J Reprod Immunol; 1998 Feb; 39(2):77-81. PubMed ID: 9506205
[TBL] [Abstract][Full Text] [Related]
29. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
[TBL] [Abstract][Full Text] [Related]
30. Bu-Shen-Yi-Qi formula impairs cytotoxicity of NK cells by up-regulating IDO expression in trophoblasts.
Yang SL; Niu TT; Li XL; Li DJ; Li MQ; Wang HY
Gynecol Endocrinol; 2018 Aug; 34(8):675-679. PubMed ID: 29334801
[TBL] [Abstract][Full Text] [Related]
31. Intralipid® may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activation.
Lédée N; Vasseur C; Petitbarat M; Chevrier L; Vezmar K; Dray G; Chenière S; Lobersztajn A; Vitoux D; Cassuto GN; Chaouat G
J Reprod Immunol; 2018 Nov; 130():18-22. PubMed ID: 30286362
[TBL] [Abstract][Full Text] [Related]
32. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
[TBL] [Abstract][Full Text] [Related]
33. Declined Natural Killer Cells Emerging in Women with Unexplained Recurrent Spontaneous Abortion and Further Reducing after Medical Therapy.
Lin X; Lin D; Liu J; Bao Y; Luo Z; Fang J; Wang Y; Zhao M; Duan C
Clin Lab; 2016 Nov; 62(11):2241-2247. PubMed ID: 28164685
[TBL] [Abstract][Full Text] [Related]
34. Intravenous immunoglobulin for treatment of recurrent pregnancy loss.
Coulam CB; Krysa L; Stern JJ; Bustillo M
Am J Reprod Immunol; 1995 Dec; 34(6):333-7. PubMed ID: 8607936
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.
Stricker RB; Steinleitner A; Bookoff CN; Weckstein LN; Winger EE
Fertil Steril; 2000 Mar; 73(3):536-40. PubMed ID: 10689009
[TBL] [Abstract][Full Text] [Related]
36. Clinical Research into Treating Unexplained Recurrent Spontaneous Abortion during Early Pregnancy with the Qing Yi Tiao Mian Formula.
Shen MJ; Pan DC; Du L; Jiang GJ
Explore (NY); 2023; 19(1):52-57. PubMed ID: 35397998
[TBL] [Abstract][Full Text] [Related]
37. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study.
Jablonowska B; Selbing A; Palfi M; Ernerudh J; Kjellberg S; Lindton B
Hum Reprod; 1999 Mar; 14(3):838-41. PubMed ID: 10221723
[TBL] [Abstract][Full Text] [Related]
38. Effects of polyvalent immunoglobulins in patients with recurrent pregnancy loss and antibodies to the choriocarcinoma cell line JEG-3.
Rogenhofer N; von Schönfeldt V; Ochsenkühn R; Sili F; Thaler CJ
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():161-7. PubMed ID: 26407335
[TBL] [Abstract][Full Text] [Related]
39. Blocking antibodies in blood from patients with recurrent spontaneous abortion in relation to pregnancy outcome and intravenous immunoglobulin treatment.
Jablonowska B; Palfi M; Ernerudh J; Kjellberg S; Selbing A
Am J Reprod Immunol; 2001 Apr; 45(4):226-31. PubMed ID: 11327549
[TBL] [Abstract][Full Text] [Related]
40. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion.
Muyayalo KP; Li ZH; Mor G; Liao AH
Am J Reprod Immunol; 2018 Oct; 80(4):e13018. PubMed ID: 29984444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
